Financhill
Back

Larimar Therapeutics Vs. Prime Medicine Industry Stock Comparison

Sell
38

LRMR
Larimar Therapeutics

Last Price:
6.85
Seasonality Move:
-2.11%
Sell
22

PRME
Prime Medicine

Last Price:
3.99
Seasonality Move:
-25.18%
Sell
38
Larimar Therapeutics (LRMR) is a Sell

Is Larimar Therapeutics a Buy, Sell or Hold?

  • The current Larimar Therapeutics [LRMR] share price is $6.81. The Score for LRMR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • LRMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Prime Medicine (PRME) is a Sell

Is Prime Medicine a Buy, Sell or Hold?

  • The current Prime Medicine [PRME] share price is $4.00. The Score for PRME is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • PRME is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LRMR Stock Price Chart

What is Larimar Therapeutics's stock price today?

  • The Larimar Therapeutics share price today is $6.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRME Stock Price Chart

What is Prime Medicine's stock price today?

  • The Prime Medicine share price today is $4.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRME is experiencing slight buying pressure.

LRMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 40.45 Sell
Chaikin Money Flow: 302776 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.24 - 8.16) Sell
Bollinger Bands (100): (7.13 - 9.09) Sell

PRME Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 45.22 Sell
Chaikin Money Flow: 198344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.87 - 4.39) Sell
Bollinger Bands (100): (4.34 - 6.58) Sell

LRMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.36 Sell
20-day SMA: 7.7 Sell
50-day SMA: 8.31 Sell
200-day SMA: 7.48 Sell
8-day EMA: 7.25 Sell
20-day EMA: 7.59 Sell
50-day EMA: 7.92 Sell
200-day EMA: 7.32 Sell

PRME Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.9 Buy
20-day SMA: 4.08 Sell
50-day SMA: 4.73 Sell
200-day SMA: 6.45 Sell
8-day EMA: 3.95 Buy
20-day EMA: 4.1 Sell
50-day EMA: 4.62 Sell
200-day EMA: 6.6 Sell

Larimar Therapeutics Earnings Growth & LRMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.43 per share.

Prime Medicine Earnings Growth & PRME Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.13 per share, an increase this year of $0.17 per share, and an increase next year of $0.21 per share.

Larimar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Prime Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):